Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Clin Pharmacol Ther. 2019 May 31;106(4):821–830. doi: 10.1002/cpt.1464

Figure 1: Model Schematics for Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide.

Figure 1:

Red boxes = blood matrices (BP/PBMCs), blue boxes = seminal matrices (SP/SMCs), gray boxes = compartments with direct measurement, doted boxes = transit compartments, dashed box = compartment not modeled, ovals = depot compartments